How Remdesivir, New Hope for Covid-19 Patients, Was Resurrected

Erin Schaff/The New York Times Remdesivir, an antiviral drug designed to treat both hepatitis and a common respiratory virus, seemed fated to join thousands of other failed medications after proving useless against those diseases. The drug was consigned to […]

Click here to view original web page at How Remdesivir, New Hope for Covid-19 Patients, Was Resurrected